Cite
HARVARD Citation
Tougeron, D. et al. (n.d.). 337 Pembrolizumab in combination with xelox bevacizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer and a high immune infiltrate: a proof of concept study. FFCD 1703 POCHI. Journal for immunotherapy of cancer. p. A206. [Online].